| FDA panel backs Boehringer's Pradaxa for stroke reduction - Pharma Times |
|
|
Pharma TimesThe US Food and Drug Administration's Cardiovascular and Renal Drugs Advisory Committee has voted 9 to 0 in favour of approving Pradaxa (dabigatran) for ...FDA panel greenlights Boehringer's AF stroke prevention drug Pradaxa Cardiovascular BusinessPanel Endorses New Blood Thinner for Afib Patients MedPage TodayUS FDA advisory backs Boehringer Ingelheim's Pradaxa, putting firm ahead in ... read more |